In the framework of objective 6 of the Cancer Plan 2014-2019 "Consolidating France’s position in personalized medicine / Generating and understanding big data", Synergie Lyon Cancer has joined with the CEA (France genomics), the Inserm, the French Institute of Bioinformatics, the Centre of Human Polymorphism Studies (CEPH), the Ligue contre le cancer and the Institut Curie, among others, to set up a national centre dedicated to genomics and the analysis of cancer data.